Media Center
Press releases
ALFASIGMA ACQUIRES THE ENTIRE SHARE CAPITAL OF SOFAR, AN ITALIAN PHARMACEUTICAL COMPANY
Alfasigma Group Redeploys CARNITENE® (L-carnitine) Business in the Chinese Market
Alfasigma launches diagnostic drug Lumeblue™ ahead of World Digestive Health on 29 May
Alfasigma inaugurates the new Research and Development center in Pomezia named after its founder Marino Golinelli
Alfasigma: Jacopo Murzi is the new General Manager of the Italy Business Unit
Alfasigma acquires Lumeblue™ (Methylene Blue MMX) rights for EU distribution, consolidating its Gastro-Intestinal portfolio
Press kit
- Our people
- Sermoneta plant
- Alanno plant
- Pomezia plant
- Therapeutic areas
- Company presentation
- Image library
Press contacts
Corporate Communications & Media Relations
Staff
[email protected] +39.051.6489.562 +39.051.6489.884 +39.06.9139.4396